Eur Rev Med Pharmacol Sci 2021; 25 (8): 3150-3150

DOI: 10.26355/eurrev_202104_25716

CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p

S.-J. Zhang, J. Ma, J.-C. Wu, Z.-Z. Hao, Y.-N. Zhang, Y.-J. Zhang

Department of Respiratory Medicine, Huaihe Hospital of Henan University, Kaifeng, China.


The article “CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p, by S.-J. Zhang, J. Ma, J.-C. Wu, Z.-Z. Hao, Y.-N. Zhang, Y.-J. Zhang, published in Eur Rev Med Pharmacol Sci 2020; 24 (7): 3749-3760–DOI: 10.26355/eurrev_202004_20839–PMID: 32329852” has been withdrawn from the authors due to inaccuracies and mistakes.

The Publisher apologizes for any inconvenience this may cause.

CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p

Free PDF Download

To cite this article

S.-J. Zhang, J. Ma, J.-C. Wu, Z.-Z. Hao, Y.-N. Zhang, Y.-J. Zhang
CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 8
Pages: 3150-3150
DOI: 10.26355/eurrev_202104_25716